These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 8147339)
1. Antibody response against tetanus toxoid is enhanced by lipopolysaccharide or tumor necrosis factor-alpha in vitamin A-sufficient and deficient rats. Arora D; Ross AC Am J Clin Nutr; 1994 Apr; 59(4):922-8. PubMed ID: 8147339 [TBL] [Abstract][Full Text] [Related]
2. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant. Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004 [TBL] [Abstract][Full Text] [Related]
3. Immunological memory to tetanus toxoid is established and maintained in the vitamin A-depleted rat. Kinoshita M; Pasatiempo AM; Taylor CE; Ross AC FASEB J; 1991 Jul; 5(10):2473-81. PubMed ID: 2065894 [TBL] [Abstract][Full Text] [Related]
4. Vitamin A status and immunoglobulin G subclasses in rats immunized with tetanus toxoid. Kinoshita M; Ross AC FASEB J; 1993 Oct; 7(13):1277-82. PubMed ID: 8405813 [TBL] [Abstract][Full Text] [Related]
5. The antibody response of vitamin A-deficient rats to pneumococcal polysaccharide is enhanced through coimmunization with lipopolysaccharide. Pasatiempo AM; Kinoshita M; Foulke DT; Ross AC J Infect Dis; 1994 Feb; 169(2):441-4. PubMed ID: 8106780 [TBL] [Abstract][Full Text] [Related]
6. Immunologic memory is established in nursling rats immunized with tetanus toxoid, but is not affected by concurrent supplementation with vitamin A. Gardner EM; Ross AC Am J Clin Nutr; 1995 Nov; 62(5):1007-12. PubMed ID: 7572724 [TBL] [Abstract][Full Text] [Related]
7. Neonatal-age treatment with vitamin A delays postweaning vitamin A deficiency and increases the antibody response to T-cell dependent antigens in young adult rats fed a vitamin A-deficient diet. Sankaranarayanan S; Ma Y; Bryson MC; Li NQ; Ross AC J Nutr; 2007 May; 137(5):1229-35. PubMed ID: 17449586 [TBL] [Abstract][Full Text] [Related]
8. All-trans-retinoic acid and polyriboinosinoic:polyribocytidylic acid cooperate to elevate anti-tetanus immunoglobulin G and immunoglobulin M responses in vitamin A-deficient lewis rats and Balb/c mice. DeCicco KL; Ross AC Proc Nutr Soc; 2000 Nov; 59(4):519-29. PubMed ID: 11115786 [TBL] [Abstract][Full Text] [Related]
9. The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid. Ma Y; Ross AC Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13556-61. PubMed ID: 16157890 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid and polyriboinosinic acid act synergistically to enhance the antibody response to tetanus toxoid during vitamin A deficiency: possible involvement of interleukin-2 receptor-beta, signal transducer and activator of transcription-1, and interferon regulatory factor-1. DeCicco KL; Zolfaghari R; Li Nq; Ross AC J Infect Dis; 2000 Sep; 182 Suppl 1():S29-36. PubMed ID: 10944482 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum. Katare YK; Panda AK Vaccine; 2006 Apr; 24(17):3599-608. PubMed ID: 16513224 [TBL] [Abstract][Full Text] [Related]
13. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations. Lum LG; Culbertson NJ J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031 [TBL] [Abstract][Full Text] [Related]
14. Impaired human responses to tetanus toxoid in vitamin A-deficient SCID mice reconstituted with human peripheral blood lymphocytes. Molrine DC; Polk DB; Ciamarra A; Phillips N; Ambrosino DM Infect Immun; 1995 Aug; 63(8):2867-72. PubMed ID: 7622207 [TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin A supplementation on immunoglobulin G subclass responses to tetanus toxoid in children. Semba RD; Muhilal ; Scott AL; Natadisastra G; West KP; Sommer A Clin Diagn Lab Immunol; 1994 Mar; 1(2):172-5. PubMed ID: 7496940 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of immune response from polymer-entrapped antigen: toward development of single dose tetanus toxoid vaccine. Katare YK; Panda AK; Lalwani K; Haque IU; Ali MM Drug Deliv; 2003; 10(4):231-8. PubMed ID: 14612338 [TBL] [Abstract][Full Text] [Related]
17. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid. Raghuvanshi RJ; Mistra A; Talwar GP; Levy RJ; Labhasetwar V J Microencapsul; 2001; 18(6):723-32. PubMed ID: 11695637 [TBL] [Abstract][Full Text] [Related]
18. Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy. Layward L; Allen AC; Harper SJ; Hattersley JM; Feehally J Clin Nephrol; 1993 Sep; 40(3):131-6. PubMed ID: 8403566 [TBL] [Abstract][Full Text] [Related]
19. Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain. Altman E; Chandan V; Harrison BA; Veloso-Pita R; Li J; KuoLee R; Chen W; Vérez-Bencomo V; Vaccine; 2012 Nov; 30(50):7332-41. PubMed ID: 22534169 [TBL] [Abstract][Full Text] [Related]
20. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen. Geha RS J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]